Cullen/Frost Bankers’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $99.7K | Buy |
2,337
+10
| +0.4% | +$447 | ﹤0.01% | 725 |
|
|
2026
Q1 | $112K | Sell |
2,327
-78
| -3% | -$3.64K | ﹤0.01% | 655 |
|
|
2025
Q4 | $117K | Buy |
2,405
+114
| +5% | +$5.65K | ﹤0.01% | 657 |
|
|
2025
Q3 | $108K | Buy |
2,291
+826
| +56% | +$39.9K | ﹤0.01% | 634 |
|
|
2025
Q2 | $70.8K | Sell |
1,465
-467
| -24% | -$23.9K | ﹤0.01% | 684 |
|
|
2025
Q1 | $107K | Buy |
1,932
+474
| +33% | +$25.7K | ﹤0.01% | 596 |
|
|
2024
Q4 | $70.3K | Buy |
1,458
+74
| +5% | +$3.76K | ﹤0.01% | 658 |
|
|
2024
Q3 | $79.8K | Buy |
1,384
+93
| +7% | +$5.02K | ﹤0.01% | 641 |
|
|
2024
Q2 | $62.6K | Buy |
1,291
+41
| +3% | +$1.98K | ﹤0.01% | 648 |
|
|
2024
Q1 | $60.8K | Hold |
1,250
| – | – | ﹤0.01% | 630 |
|
|
2023
Q4 | $62.2K | Sell |
1,250
-223
| -15% | -$10.9K | ﹤0.01% | 632 |
|
|
2023
Q3 | $79K | Buy |
1,473
+104
| +8% | +$5.54K | ﹤0.01% | 648 |
|
|
2023
Q2 | $73.8K | Buy |
1,369
+187
| +16% | +$10.1K | ﹤0.01% | 668 |
|
|
2023
Q1 | $64.3K | Buy |
1,182
+182
| +18% | +$8.85K | ﹤0.01% | 680 |
|
|
2022
Q4 | $48.4K | Sell |
1,000
-911
| -48% | -$40K | ﹤0.01% | 707 |
|
|
2022
Q3 | $73K | Buy |
1,911
+545
| +40% | +$24.3K | ﹤0.01% | 646 |
|
|
2022
Q2 | $68K | Buy |
1,366
+337
| +33% | +$17.9K | ﹤0.01% | 657 |
|
|
2022
Q1 | $53K | Hold |
1,029
| – | – | ﹤0.01% | 735 |
|
|
2021
Q4 | $52K | Sell |
1,029
-702
| -41% | -$34.7K | ﹤0.01% | 745 |
|
|
2021
Q3 | $83K | Hold |
1,731
| – | – | ﹤0.01% | 653 |
|
|
2021
Q2 | $91K | Hold |
1,731
| – | – | ﹤0.01% | 658 |
|
|
2021
Q1 | $86K | Sell |
1,731
-7,369
| -81% | -$354K | ﹤0.01% | 632 |
|
|
2020
Q4 | $442K | Sell |
9,100
-50
| -0.5% | -$2.47K | 0.01% | 373 |
|
|
2020
Q3 | $459K | Buy |
9,150
+7,419
| +429% | +$382K | 0.01% | 349 |
|
|
2020
Q2 | $88K | Buy |
1,731
+881
| +104% | +$42.8K | ﹤0.01% | 558 |
|
|
2020
Q1 | $37K | Buy |
850
+119
| +16% | +$5.69K | ﹤0.01% | 542 |
|
|
2019
Q4 | $37K | Hold |
731
| – | – | ﹤0.01% | 655 |
|
|
2019
Q3 | $34K | Sell |
731
-155
| -17% | -$6.68K | ﹤0.01% | 629 |
|
|
2019
Q2 | $39K | Buy |
886
+89
| +11% | +$3.79K | ﹤0.01% | 597 |
|
|
2019
Q1 | $35K | Buy |
+797
| New | +$34.1K | ﹤0.01% | 610 |
|
|
2016
Q3 | – | Sell |
-7,947
| Closed | -$332K | – | 375 |
|
|
2016
Q2 | $332K | Sell |
7,947
-162
| -2% | -$6.64K | 0.01% | 307 |
|
|
2016
Q1 | $325K | Buy |
8,109
+185
| +2% | +$7.43K | 0.01% | 311 |
|
|
2015
Q4 | $338K | Sell |
7,924
-333
| -4% | -$15.3K | 0.01% | 302 |
|
|
2015
Q3 | $392K | Buy |
8,257
+1,199
| +17% | +$61K | 0.02% | 295 |
|
|
2015
Q2 | $349K | Hold |
7,058
| – | – | 0.01% | 322 |
|
|
2015
Q1 | $349K | Sell |
7,058
-442
| -6% | -$21.1K | 0.01% | 324 |
|
|
2014
Q4 | $342K | Buy |
7,500
+100
| +1% | +$4.85K | 0.01% | 335 |
|
|
2014
Q3 | $417K | Sell |
7,400
-234
| -3% | -$12.6K | 0.02% | 313 |
|
|
2014
Q2 | $406K | Sell |
7,634
-651
| -8% | -$34.6K | 0.02% | 311 |
|
|
2014
Q1 | $434K | Buy |
8,285
+3,340
| +68% | +$169K | 0.02% | 296 |
|
|
2013
Q4 | $265K | Buy |
4,945
+504
| +11% | +$26K | 0.01% | 334 |
|
|
2013
Q3 | $225K | Sell |
4,441
-330
| -7% | -$16.8K | 0.01% | 349 |
|
|
2013
Q2 | $245K | Buy |
+4,771
| New | +$254K | 0.01% | 333 |
|
Other funds holding SNY
MIP
DC
FRM
EIP
TWC
GF
GP
Cullen/Frost Bankers's SNY Position: Q2 2026 in Review
Cullen/Frost Bankers increased its Sanofi (SNY) stake by 0.43% in Q2 2026, buying an estimated $447 and bringing the position to 2,337 shares worth $99.7K. The position accounts for ﹤0.01% of the portfolio, ranked #725.
Cullen/Frost Bankers first reported a position in SNY in Q2 2013 and has held it in 43 quarters since. The position peaked at $459K in Q3 2020. 262 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Cullen/Frost Bankers held 2,337 shares of Sanofi worth $99.7K as of Q2 2026.
- Cullen/Frost Bankers bought 10 Sanofi shares in Q2 2026, an estimated $447.
- Sanofi made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #725 holding.
- Cullen/Frost Bankers first reported a position in Sanofi in Q2 2013 and has held it in 43 quarters since.
- Cullen/Frost Bankers's Sanofi position peaked at $459K in Q3 2020.
- 262 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.